IP Library Granted Patent US 7,071,324
Granted Patent B2
US 7,071,324 · App. 10/095,363 · Granted Jul 4, 2006

Systems and methods for sequencing by hybridization

Assignee: Brown University Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,071,324
App. No.
10/095,363
Granted
Jul 4, 2006
Kind
B2
Abstract

The systems and methods described herein relate to nucleic acid probes comprising a pattern of universal and designate nucleotides (or analogs thereof), or ‘gapped’ probes, and the use of sets of gapped probes in sequencing by hybridization to determine the sequence of nucleic acid sequences. The inclusion of universal nucleotides in the probes allows for efficient and rapid sequencing of longer nucleotide sequences than can be sequenced using traditional probes. The systems and methods described herein also relate to apparatus for sequencing nucleic acids which include gapped probes, as well as computer systems capable of analyzing data generated using gapped probes in such apparatus.

Claims (21)

1. A gapped probe, comprising a sequence of universal and designate nucleotides and/or nucleotide analogs ordered in a predetermined pattern, wherein the pattern has a reduced shift-overlap count such that no shifted count is greater than 60% of the perfect count.

2. The probe of claim 1 , having a universal nucleotide selected from the group consisting of 5-nitroindole, 3-nitropyrrole and deoxyinosine.

3. The probe of claim 1 , further comprising at least two contiguous designate nucleotides and/or nucleotide analogs bound to an end of the sequence of universal and designate nucleotides and/or nucleotide analogs ordered in a predetermined pattern.

4. The probe of claim 1 , wherein at least one of the designate nucleotides and/or nucleotide analogs is a nucleotide analog.

5. The probe of claim 4 , wherein the nucleotide analog is selected from the group consisting of: a peptide nucleic acid, pyranosyl-RNA, a hexitol nucleic acid, a mannitol nucleic acid, an altritol nucleic acid, a 2′–5′ nucleic acid, a locked nucleic acid, a seco-locked nucleic acid, a bicyclo[3.2.1]DNA, a bicyclo[3.3.0]DNA, a tricyclo-DNA, 3-hydroxy-N-acetylprolinol substituted nucleic acid, a carbocyclic nucleic acid, a carbocyclic/bicyclic nucleic acid, a nucleic acid with a triazole backbone, a nucleic acid with an imidazole backbone, a 1-phenylserinol nucleic acid, a nucleic acid with an alpha anomer backbone, and a metal-linked nucleic acid.

6. A gapped probe, comprising a sequence of universal and designate nucleotides and/or nucleotide analogs ordered in a pattern, wherein the pattern comprises a root and an iterated unit, and wherein the length of the root is identical to the length of the iterated unit, and wherein the probe comprises at least one nucleotide analog selected from the group consisting of: a peptide nucleic acid, pyranosyl-RNA, a hexitol nucleic acid, a mannitol nucleic acid, an altritol nucleic acid, a 2′–5′ nucleic acid, a locked nucleic acid, a seco-locked nucleic acid, a bicyclo-DNA, a bicyclo[3.3.0]DNA, a tricyclo-DNA, 3-hydroxy-N-acetylprolinol substituted nucleic acid, a carbocyclic nucleic acid, a carbocyclic/bicyclic nucleic acid, a nucleic acid with a triazole backbone, a nucleic acid with an imidazole backbone, a 1-phenylserinol nucleic acid, a nucleic acid with an alpha anomer backbone, and a metal-linked nucleic acid.

7. A gapped probe of claim 6 , wherein each iterated unit comprises a string of universal nucleotides and/or nucleotide analogs followed by one or more designate nucleotide and/or nucleotide analog.

8. A set of gapped probes, comprising a plurality of instances of a sequence of universal and designate nucleotides and/or nucleotide analogs ordered in a predetermined pattern, wherein the pattern has a reduced shift-overlap count such that no shifted count is greater than 60% of the perfect count.

9. The set of gapped probes of claim 8 , comprising a universal nucleotide selected from the group consisting of 5-nitroindole, 3-nitropyrrole and deoxyinosine.

10. The set of gapped probes of claim 8 , wherein the probes are displayed in a spatially defined array.

11. The set of gapped probes of claim 8 , wherein the probes are displayed on a solid support.

12. The set of gapped probes of claim 8 , wherein the probes are displayed on or in a semisolid matrix.

13. The set of gapped probes of claim 8 , wherein the probes are displayed in a matrix of fluid-containing chambers.

14. The set of gapped probes of claim 8 , wherein at least one of the nucleotides and/or nucleotide analogs is a nucleotide analog.

15. The set of gapped probes of claim 14 , wherein the nucleotide analog is selected from the group consisting of: a peptide nucleic acid, pyranosyl-RNA, a hexitol nucleic acid, a mannitol nucleic acid, an altritol nucleic acid, a 2′–5′ nucleic acid, a locked nucleic acid, a seco-locked nucleic acid, a bicyclo-DNA, a bicyclo-DNA, a tricyclo-DNA, 3-hydroxy-N-acetylprolinol substituted nucleic acid, a carbocyclic nucleic acid, a carbocyclic/bicyclic nucleic acid, a nucleic acid with a triazole backbone, a nucleic acid with an imidazole backbone, a 1-phenylserinol nucleic acid, a nucleic acid with an alpha anomer backbone, and a metal-linked nucleic acid.

16. A probe array, comprising a substrate, and a set of gapped probes disposed thereon, wherein each probe comprises an instance of a predetermined pattern of universal and designate nucleotides and/or nucleotide analogs such that the set comprises a plurality of instances of the pattern, wherein the predetermined pattern has a reduced shift-overlap count such that no shifted count is greater than 60% of the perfect count.

17. The array of claim 16 , wherein the predetermined pattern is iterative.

18. The array of claim 16 , having a universal nucleotide selected from the group consisting of 5-nitroindole, 3-nitropyrrole and inosine.

19. The array of claim 16 , wherein each particular instance of a predetermined pattern is associated with a particular location on the array.

20. The array of claim 16 , wherein at least one of the nucleotides and/or nucleotide analogs is a nucleotide analog.

21. The array of claim 20 , wherein the nucleotide analog is selected from the group consisting of: a peptide nucleic acid, pyranosyl-RNA, a hexitol nucleic acid, a mannitol nucleic acid, an altritol nucleic acid, a 2′–5′ nucleic acid, a locked nucleic acid, a seco-locked nucleic acid, a bicyclo-DNA, a bicyclo-DNA, a tricyclo-DNA, 3-hydroxy-N-acetylprolinol substituted nucleic acid, a carbocyclic nucleic acid, a carbocyclic/bicyclic nucleic acid, a nucleic acid with a triazole backbone, a nucleic acid with an imidazole backbone, a 1-phenylserinol nucleic acid, a nucleic acid with an alpha anomer backbone, and a metal-linked nucleic acid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2015
From: NABSYS, INC.
To: NABSYS 2.0 LLC
Reel/Frame 037142/0357 →
SECURITY INTEREST Recorded Nov 10, 2015
From: NABSYS 2.0 LLC (SUCCESSOR-IN-INTEREST TO NABSYS, INC. AND LICENSEE FROM BROWN UNIVERSITY)
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 036998/0895 →
RELEASE OF SECURITY INTEREST Recorded Aug 18, 2014
From: VENTURE LENDING & LEASING VI, INC.
To: NABSYS, INC.
Reel/Frame 033554/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2002
From: PREPARATA, FRANCO; UPFAL, ELIEZER; OLIVER, JOHN S.
To: BROWN UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 013159/0300 →
Continuity (5)
Continuation In Part 0973577600 · Dec 13, 2000
Division 0941677900 · Oct 13, 1999
Provisional Application 6010399800 · Oct 13, 1998
Provisional Application 6012570400 · Mar 23, 1999
Related Publication 20030064382A1 · Apr 3, 2003